Andere talen Amneal Pharmaceuticals, Inc.

Aandelen

AMRX

US03168L1052

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 07-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6,75 ^USD	+0,90%		+1,05%	+11,20%

05/06	Transcript : Amneal Pharmaceuticals, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 01:30 PM
05/06	Amneal Pharmaceuticals, Inc. breidt brede portefeuille injectables uit tot meer dan 40 producten met de toevoeging van zes nieuwe therapieën	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Amneal Pharmaceuticals : Jefferies Global Healthcare Conference 2024	05/06
Amneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New Therapies	05/06
Amneal Pharmaceuticals, Inc. Expands Broad Injectables Portfolio to over 40 Products with the Addition of Six New Therapies	05/06
Amneal Pharmaceuticals Begins Supplying Generic Version of Narcan	22/05
Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California	22/05
Amneal to Participate at Upcoming Investor Conference	22/05
Amneal Begins Supplying Over-The-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California	22/05
Amneal Reports First Quarter 2024 Financial Results	06/05
Drugmaker Amneal agrees to $270 million U.S. opioid settlement	03/05
Sector Update: Health Care Stocks Mixed Pre-Bell Friday	03/05
Amneal Pharmaceuticals Q1 Adjusted Earnings, Revenue Climb	03/05
Amneal Pharmaceuticals : First Quarter 2024 Earnings Presentation	03/05
(AMRX) AMNEAL PHARMACEUTICALS Forecasts Fiscal Year 2024 EPS Range $0.53 - $0.63	03/05
Earnings Flash (AMRX) AMNEAL PHARMACEUTICALS Reports Q1 Revenue $659.2M, vs. Street Est of $619M	03/05
Earnings Flash (AMRX) AMNEAL PHARMACEUTICALS Posts Q1 EPS $0.14, vs. Street Est of $0.09	03/05
North American Morning Briefing : Apple, Amgen -2-	03/05
Amneal: Q1 Earnings Snapshot	03/05
Amneal Reports First Quarter 2024 Financial Results	03/05
Amneal Pharmaceuticals, Inc. Affirms Earnings Guidance for Full Year 2024	03/05
Amneal Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	03/05

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Amneal Pharmaceuticals, Inc.

Aandelen

AMRX

US03168L1052

Andere talen

Filters